# Targeting of Immune Response After Pneumococcal Vaccination

> **NCT01402245** · PHASE4 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 42 (actual)

## Conditions studied

- Pneumococcal Pneumonia

## Interventions

- **BIOLOGICAL:** Pneumococcal polysaccharide vaccine
- **BIOLOGICAL:** pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT01402245
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2011-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402245, "Targeting of Immune Response After Pneumococcal Vaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01402245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*